These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21865159)

  • 41. Calcitriol treatment increases serum levels of the soluble receptor of advanced glycation end products in hemodialysis patients with secondary hyperparathyroidism.
    Sung JY; Chung W; Kim AJ; Kim HS; Ro H; Chang JH; Lee HH; Jung JY
    Tohoku J Exp Med; 2013 May; 230(1):59-66. PubMed ID: 23748365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line.
    Chuong C; Katz J; Pauley KM; Bulosan M; Cha S
    J Cell Physiol; 2009 Nov; 221(2):430-4. PubMed ID: 19591173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer.
    Jing R; Cui M; Wang J; Wang H
    Neoplasma; 2010; 57(1):55-61. PubMed ID: 19895173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular disease: what's all the AGE/RAGE about?
    Barlovic DP; Thomas MC; Jandeleit-Dahm K
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):7-15. PubMed ID: 20041839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes.
    Tsoporis JN; Hatziagelaki E; Gupta S; Izhar S; Salpeas V; Tsiavou A; Rigopoulos AG; Triantafyllis AS; Marshall JC; Parker TG; Rizos IK
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33182705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
    Penumutchu SR; Chou RH; Yu C
    PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy.
    Ng ZX; Kuppusamy UR; Iqbal T; Chua KH
    Gene; 2013 Jun; 521(2):227-33. PubMed ID: 23545311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients.
    Nakashima A; Carrero JJ; Qureshi AR; Miyamoto T; Anderstam B; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2213-9. PubMed ID: 20847094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
    Prasad K; Tiwari S
    Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
    Forbes JM; Thorpe SR; Thallas-Bonke V; Pete J; Thomas MC; Deemer ER; Bassal S; El-Osta A; Long DM; Panagiotopoulos S; Jerums G; Osicka TM; Cooper ME
    J Am Soc Nephrol; 2005 Aug; 16(8):2363-72. PubMed ID: 15930093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RAGE processing in chronic airway conditions: involvement of Staphylococcus aureus and ECP.
    Van Crombruggen K; Holtappels G; De Ruyck N; Derycke L; Tomassen P; Bachert C
    J Allergy Clin Immunol; 2012 Jun; 129(6):1515-21.e8. PubMed ID: 22460069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1.
    Pullerits R; Brisslert M; Jonsson IM; Tarkowski A
    Arthritis Rheum; 2006 Dec; 54(12):3898-907. PubMed ID: 17133598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
    Tesarová P; Kalousová M; Jáchymová M; Mestek O; Petruzelka L; Zima T
    Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clearance kinetics and matrix binding partners of the receptor for advanced glycation end products.
    Milutinovic PS; Englert JM; Crum LT; Mason NS; Ramsgaard L; Enghild JJ; Sparvero LJ; Lotze MT; Oury TD
    PLoS One; 2014; 9(3):e88259. PubMed ID: 24642901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis.
    Chen YS; Yan W; Geczy CL; Brown MA; Thomas R
    Arthritis Res Ther; 2009; 11(2):R39. PubMed ID: 19284577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation.
    Buhimschi IA; Zhao G; Pettker CM; Bahtiyar MO; Magloire LK; Thung S; Fairchild T; Buhimschi CS
    Am J Obstet Gynecol; 2007 Feb; 196(2):181.e1-13. PubMed ID: 17306673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels.
    Kim HS; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
    Nephrology (Carlton); 2013 Dec; 18(12):777-82. PubMed ID: 24124651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural and functional insights into RAGE activation by multimeric S100B.
    Ostendorp T; Leclerc E; Galichet A; Koch M; Demling N; Weigle B; Heizmann CW; Kroneck PM; Fritz G
    EMBO J; 2007 Aug; 26(16):3868-78. PubMed ID: 17660747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of the receptor for advanced glycation end products in liver transplantation.
    Navarra T; De Simone P; Del Turco S; Filipponi F; Basta G
    Ann Hepatol; 2015; 14(2):190-7. PubMed ID: 25671828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.